Metabolic profiling of cholesterol and sex steroid hormones to monitor urological diseases. Issue 10 (October 2016)

• Record Type: Journal Article
• Authors: Moon, Ju-Yeon; Choi, Man Ho; Kim, Jayoung
• Is Part Of: Endocrine-related cancer. Volume 23:Issue 10(2016)
• Page Start: R455
• Page End: R467
• Publication Date: 2016-10
• Subjects: steroid -- cholesterol -- biomarkers -- mass spectrometry -- metabolomics -- urological cancers -- prostate diseases; Endocrine glands -- Cancer -- Periodicals; Endocrinology -- Periodicals; Cancer -- Endocrine aspects -- Periodicals; 616.9944005
• DOI: 10.1530/ERC-16-0285
• Languages: English
• ISSNs: 1351-0088

Abstract

Abstract : Cholesterol and sex steroid hormones including androgens and estrogens play a critical role in the development and progression of urological diseases such as prostate cancer. This disease remains the most commonly diagnosed malignant tumor in men and is the leading cause of death from different cancers. Attempts to understand the role of cholesterol and steroid metabolism in urological diseases have been ongoing for many years, but despite this, our mechanistic and translational understanding remains elusive. In order to further evaluate the problem, we have taken an interest in metabolomics; a discipline dedicated to the systematic study of biologically active metabolites in cells, tissues, hair and biofluids. Recently, we provided evidence that a quantitative measurement of cholesterol and sex steroid metabolites can be successfully achieved using hair of human and mouse models. The overall goal of this short review article is to introduce current metabolomic technologies for the quantitative biomarker assay development and also to provide new insight into understanding the underlying mechanisms that trigger the pathological condition. Furthermore, this review will place a particular emphasis on how to prepare biospecimens (e.g., hair fiber), quantify molecular profiles and assess their clinical significance in various urological diseases.